PE59699A1 - 2,4 diaminopirimidina sustituida - Google Patents
2,4 diaminopirimidina sustituidaInfo
- Publication number
- PE59699A1 PE59699A1 PE1998000142A PE00014298A PE59699A1 PE 59699 A1 PE59699 A1 PE 59699A1 PE 1998000142 A PE1998000142 A PE 1998000142A PE 00014298 A PE00014298 A PE 00014298A PE 59699 A1 PE59699 A1 PE 59699A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- alcoxyl
- aryl
- compound
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA (I) O SUS SALES DONDE, R1 ES ALCOXILO, R2 ES OH O ALCOXILO; R3 ES CN, H, ALQUILO, ALQUENILO, CICLOALQUILO, ARILO, HETEROCICLO, ARIL-Q-ALQUILO, -CR4R4`COR5; ENTRE OTROS; Q ES SO o SO2; R4 Y R4' SON H, ALQUILO, ARILO, HETEROCICLO; R5 ES H, ALQUILO, ALCOXILO, ENTRE OTROS; o R4 Y R5 FORMAN JUNTOS UN GRUPO CR4R4'COR5, n ES 2-5. SON COMPUESTOS PREFERIDOS (E)-(RS)-3-[5-(2,4-DIAMINO-PIRIMIDIN-5-ILMETIL)-2,3-DIMETOXIFENIL]-1-(1-FENIL-1H-FTALAZIN-2-IL)PROPENONA; (E)-(RS)-3-[5-(2,4-DIAMINO-PIRIMIDIN-5-ILMETIL)-2,3-DIMETOXI-FENIL]-1-(1-FURAN-2-IL-1H-FTALAZIN-2-IL)-PROPENONA; ENTRE OTROS. TAMBIEN SE REFIERE A PROCEDIMIENTOS PARA SU OBTENCION Y A UNA PREPARACION FARMACEUTICA QUE CONTIENE UN COMPUESTO DE FORMULA (I) Y UNA SULFONAMIDA, EN UNA PROPORCION PREFERIDA DE 1:10 A 1:2 PARTES EN PESO. EL COMPUESTO DE FORMULA (I) PUEDE SER UTIL PARA EL TRATAMIENTO DE INFECCIONES
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97103436 | 1997-03-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE59699A1 true PE59699A1 (es) | 1999-06-16 |
Family
ID=8226543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE1998000142A PE59699A1 (es) | 1997-03-03 | 1998-02-27 | 2,4 diaminopirimidina sustituida |
Country Status (21)
Country | Link |
---|---|
US (1) | US6114330A (es) |
JP (1) | JP4174077B2 (es) |
KR (1) | KR20000075888A (es) |
CN (1) | CN1091109C (es) |
AR (1) | AR011879A1 (es) |
AT (1) | ATE241618T1 (es) |
AU (1) | AU726836B2 (es) |
BR (1) | BR9808135A (es) |
CA (1) | CA2281642C (es) |
CO (1) | CO4940508A1 (es) |
DE (1) | DE69815072T2 (es) |
DK (1) | DK0966464T3 (es) |
ES (1) | ES2198705T3 (es) |
HR (1) | HRP980110A2 (es) |
MA (1) | MA26475A1 (es) |
PE (1) | PE59699A1 (es) |
PT (1) | PT966464E (es) |
TR (1) | TR199902140T2 (es) |
TW (1) | TW464648B (es) |
UY (1) | UY24913A1 (es) |
ZA (1) | ZA981529B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040162333A1 (en) * | 2003-02-19 | 2004-08-19 | Naima Mezaache | Rapid absorption selective 5-HT agonist formulations |
US8268825B2 (en) * | 2005-09-26 | 2012-09-18 | The Board Of Regents For Oklahoma State University | Method for the treatment of anthrax infections |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ296532A (en) * | 1994-11-24 | 2000-02-28 | F | Substituted 5-benzyl-2,4,-diaminopyrimidines |
TW438796B (en) * | 1996-05-15 | 2001-06-07 | Hoffmann La Roche | 2,4-diaminopyrimidine derivatives, the manufacture process thereof, and the antibiotically-active pharmaceutical composition containing the same |
-
1998
- 1998-02-24 AU AU68231/98A patent/AU726836B2/en not_active Ceased
- 1998-02-24 CN CN98803085A patent/CN1091109C/zh not_active Expired - Fee Related
- 1998-02-24 TR TR1999/02140T patent/TR199902140T2/xx unknown
- 1998-02-24 BR BR9808135-7A patent/BR9808135A/pt not_active IP Right Cessation
- 1998-02-24 CA CA002281642A patent/CA2281642C/en not_active Expired - Fee Related
- 1998-02-24 AT AT98913585T patent/ATE241618T1/de not_active IP Right Cessation
- 1998-02-24 ES ES98913585T patent/ES2198705T3/es not_active Expired - Lifetime
- 1998-02-24 DK DK98913585T patent/DK0966464T3/da active
- 1998-02-24 PT PT98913585T patent/PT966464E/pt unknown
- 1998-02-24 KR KR1019997007967A patent/KR20000075888A/ko not_active Application Discontinuation
- 1998-02-24 DE DE69815072T patent/DE69815072T2/de not_active Expired - Lifetime
- 1998-02-24 JP JP53811598A patent/JP4174077B2/ja not_active Expired - Fee Related
- 1998-02-24 ZA ZA981529A patent/ZA981529B/xx unknown
- 1998-02-25 US US09/028,980 patent/US6114330A/en not_active Expired - Lifetime
- 1998-02-26 AR ARP980100859A patent/AR011879A1/es not_active Application Discontinuation
- 1998-02-27 PE PE1998000142A patent/PE59699A1/es not_active Application Discontinuation
- 1998-02-27 CO CO98010856A patent/CO4940508A1/es unknown
- 1998-03-02 UY UY24913A patent/UY24913A1/es not_active Application Discontinuation
- 1998-03-02 MA MA24985A patent/MA26475A1/fr unknown
- 1998-03-03 TW TW087103084A patent/TW464648B/zh active
- 1998-03-03 HR HR97103436.8A patent/HRP980110A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TW464648B (en) | 2001-11-21 |
ATE241618T1 (de) | 2003-06-15 |
CN1249751A (zh) | 2000-04-05 |
TR199902140T2 (en) | 2000-04-21 |
BR9808135A (pt) | 2000-03-28 |
CA2281642A1 (en) | 1998-09-11 |
AR011879A1 (es) | 2000-09-13 |
ES2198705T3 (es) | 2004-02-01 |
KR20000075888A (ko) | 2000-12-26 |
AU726836B2 (en) | 2000-11-23 |
JP2001513791A (ja) | 2001-09-04 |
MA26475A1 (fr) | 2004-12-20 |
US6114330A (en) | 2000-09-05 |
DE69815072D1 (de) | 2003-07-03 |
ZA981529B (en) | 1998-09-03 |
CN1091109C (zh) | 2002-09-18 |
JP4174077B2 (ja) | 2008-10-29 |
PT966464E (pt) | 2003-09-30 |
AU6823198A (en) | 1998-09-22 |
CA2281642C (en) | 2008-02-05 |
UY24913A1 (es) | 2001-01-31 |
DE69815072T2 (de) | 2004-04-01 |
CO4940508A1 (es) | 2000-07-24 |
HRP980110A2 (en) | 1998-12-31 |
DK0966464T3 (da) | 2003-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ511394A (en) | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity | |
BRPI0213243B8 (pt) | composto heterocíclico aromático contendo um anel oxazol, tiazol ou imidazol, ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica | |
DE122006000027I2 (de) | Aminderivate | |
DE60020584D1 (de) | Verbindungen zur floureszenz-kennzeichnung | |
PE20030226A1 (es) | Compuestos arilicos sustituidos con quinuclidinas para el tratamiento de enfermedades | |
EA200400893A1 (ru) | N-арил-2-оксазолидинон-5-карбоксамиды, их производные и их применение в качестве антибактериальных средств | |
ATE69815T1 (de) | Neue nitromethylen-derivate. | |
BR8700921A (pt) | Processo para a preparacao de 1-arilpirazois,composicoes praguicidas,processos para combater insetos e para a preparacao de composicoes | |
BR8704389A (pt) | Composicao de pintura e processo para a protecao de uma substancia de pintura | |
PE59699A1 (es) | 2,4 diaminopirimidina sustituida | |
PE20001241A1 (es) | Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores | |
DK335384A (da) | 5-aminomethyl-1,3-oxathiolaner, fremgangsmaade til deres fremstilling og deres anvendelse, samt fremgangsmaade til fremstilling af 1,3-oxathiolaner som mellemprodukt | |
SE8303913L (sv) | Heterocykliska foreningar | |
FI933755A (fi) | Foerfarande foer framstaellning av trans-piperidin-2,5-dikarboxylater | |
KR910015537A (ko) | 신규 1-아릴술포닐-2-피페리디논 유도체, 이의 제조방법, 제조용 중간체, 의약품으로서의 용도 및 이 화합물을 함유하는 조성물 | |
SE7712733L (sv) | Substituerade o-fenylendiaminderivat, sett for framstellning samt anvendning derav som lekemedel | |
AR013004A1 (es) | Derivados de aminospiropiperidina quinazolina, composicion farmaceutica, uso de dichos derivados en la preparacion de medicamentos, proceso para lapreparacion de dichos derivados y compuestos intermediarios para su exclusivo uso en dicho proceso. | |
NO841451L (no) | Fremgangsmaate ved fremstilling av disubstituerte polymetyleniminer | |
ES2174077T3 (es) | Derivados de hidroxilamina antiisquemicos y composiciones farmaceuticas. | |
EP0982029A4 (en) | PREVENTIVE / MEDICINE FOR ARTERIOSCLEROSIS | |
FI871253A (fi) | 1-/3-(2-dialkylaminoetoxi)-2 -tienyl/-3-fenyl-1-propanoner och deras syraadditionssalter, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska sammansaettningar. | |
DK105185A (da) | Fungicide midler og deres anvendelse, deri anvendte 3-hydrazino-1,2-benzisothiazol-1,1-dioxidderivater samt disses fremstilling | |
DK0413278T3 (da) | Anvendelse af xanthinderivater mod mavesår | |
ATE5724T1 (de) | Guanidinverbindungen, verfahren zu deren herstellung und diese enthaltende zusammensetzungen. | |
KR910021373A (ko) | 1-페녹시카보닐-2-피롤리디논 유도체 및 향정신성 약제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |